Pharmaceutical Diluent Recalled for Lack of Sterility Assurance
Olympia Compounding Pharmacy is recalling pharmaceutical diluent vials due to lack of sterility assurance. The product was distributed nationwide in the USA, Puerto Rico, and US Virgin Islands.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II pharmaceutical recall with no reported illnesses or injuries in the source material. The hazard (lack of sterility assurance) is preventive in nature, but pharmaceutical sterility is critical for patient safety, and nationwide distribution presents a risk-of-harm scenario without yet-reported injury.
Plain-English summary
Olympia Compounding Pharmacy, located in Orlando, Florida, is recalling Diluent for Reconstitution Multi-Dose 10 mL vials (NDC 73198-0113-10) due to lack of assurance of sterility. A total of 42,722 vials have been recalled.
The pharmaceutical diluent is used in healthcare settings to reconstitute medications for patient use. A lack of sterility assurance in pharmaceutical diluents presents a risk to patients who receive medications reconstituted with these products, as sterile quality is essential for injectable medications and other critical-care pharmaceutical products.
The affected product was distributed nationwide in the United States, Puerto Rico, and the US Virgin Islands. The recall involves multiple lot numbers with Beyond-Use Dates ranging from October 2022 through February 2023, including lots J24125, J24025, K24002, L24013, L24213, A24003, A24404, A24031-22, and B24001-22.
Healthcare providers and patients should immediately discontinue use of the recalled product. Questions or reports of adverse events can be directed to Olympia Compounding Pharmacy or the FDA.
The recalled product
- Product
- Diluent for Reconstitution Multi-Dose 10 mL vial, Rx Only, Olympia Pharmaceuticals, 6700 Conroy Rd., Ste. 155 Orlando, FL 32835, NDC 73198-0113-10
- Category
- Drug — Pharmaceutical Diluent
- Hazard
- Affected units
- 42,722
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (9)
- Lots: J24125
- J24025 BUD: 10/25/2022
- K24002 BUD: 11/2/2022
- L24013
- L24213 BUD: 12/13/2022
- A24003 BUD: 1/3/2023
- A24404 BUD: 1/4/2023
- A24031-22 BUD: 1/31/2023
- B24001-22 BUD: 2/1/2023
Distribution
Part of a larger recall action
This product is one of 53 recalled by Olympia Compounding Pharmacy dba Olympia Pharmacy under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 53 products in this recall →Related recalls
Same manufacturer · Olympia Compounding Pharmacy dba Olympia Pharmacy
See all →- HighLidocaine 2% injectable solution recalled for lack of sterility assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Compounded Papaverine Injection Due to Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighFDA Recalls Testosterone Cypionate Injection Vials for Lack of Sterility Assurance
FDA (Drugs) · 2022-06-01
- HighCompounded pharmaceutical vials recalled due to sterility assurance failure
FDA (Drugs) · 2022-06-01
- HighOndansetron Hydrochloride vials recalled due to sterility assurance concerns
FDA (Drugs) · 2022-06-01
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24